SEC Filing Summary: Form 13F Information Table
Business Context and Reporting Period
Company: OLD REPUBLIC INTERNATIONAL CORP
Filing Type: Form 13F Information Table
Reporting Period: The filing text lists a period of "2026 Jun 30" in metadata, but the document content itself does not explicitly state the quarter-end date. Form 13F filings typically report holdings as of the end of the preceding quarter.
Context: This filing discloses the equity securities held by Old Republic International Corp, a registered investment manager, as required by the Securities Exchange Act of 1934.
Key Financial Metrics and Portfolio Composition
The filing provides a list of equity holdings rather than the company's own financial performance (revenue, profit, cash flow). The following metrics are derived from the disclosed portfolio:
- Total Disclosed Positions: 53 individual equity securities.
- Investment Authority: All listed positions are held with "SOLE" voting authority.
- Derivatives: No put or call options are reported (Column 6 and 7 are empty).
- Top Holdings by Share Count:
- Pfizer (1,963,700 shares)
- Brown-Forman (1,103,400 shares)
- Coca-Cola (991,300 shares)
- OGE Energy (862,500 shares)
- Merck & Co (705,600 shares)
- Top Holdings by Reported Value:
- Johnson & Johnson ($78,010,000)
- Merck & Co ($90,678,000)
- Cisco Systems ($75,022,000)
- Procter & Gamble ($73,651,000)
- Texas Instruments ($70,242,000)
Note: The filing does not provide the company's own revenue, profit, cash flow, debt, or liquidity metrics.
Material Changes
The filing text does not provide comparative data from the prior reporting period. Therefore, material changes in holdings, additions, or deletions cannot be determined from this document alone.
Guidance, Outlook, and Risks
Management Commentary: None provided. Form 13F is a regulatory disclosure of holdings and does not contain management discussion or analysis.
Guidance/Outlook: Not applicable.
Risks/Contingencies: The filing includes a standard disclaimer that the SEC has not reviewed the information for accuracy or completeness. No specific risk factors or contingencies regarding the portfolio are disclosed in this text.
Key Facts for Investor Verification
- Portfolio Concentration: Verify the total market value of the portfolio to assess concentration risk relative to the company's total assets.
- Reporting Date Accuracy: Confirm the actual quarter-end date, as the metadata "2026 Jun 30" appears inconsistent with standard filing timelines if this is a historical document.
- Derivative Exposure: Confirm that the absence of reported puts/calls in this table reflects the total derivative exposure, as some strategies may be reported differently.
- Industry Exposure: The portfolio shows significant exposure to Utilities (e.g., Duke Energy, Southern, Xcel Energy), Healthcare (e.g., Pfizer, Merck, J&J), and Consumer Staples (e.g., Coca-Cola, P&G).
- Voting Control: Verify that "SOLE" voting authority applies to all positions, indicating no shared management agreements for these specific holdings.